The IPO Buzz: Caris Life Sciences (CAI Proposed) Raises IPO Price Range to $19-$20
Caris Life Sciences, Inc. (CAI Proposed), an AI TechBio precision medicine pioneer focused on cancer, increased its IPO price range to $19.00 to $20.00 – up from its initial price range of $16.00 to $18.00 – and kept the number of shares at 23.53 million shares – to raise $458.84 million, if priced at $19.50, the mid-point of its new range, according to an S-1/A filing early today – Monda..
Read more June 16, 2025IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Caris Life Sciences, Inc. | CAI | 23.5 | $ 458.8 mil | 6/18/2025 Wednesday | S/O | S/O |
| Happy City Holdings Limited | HCHL | 1.0 | $ 6.0 mil | 6/18/2025 Week of | S/O | S/O |
| Slide Insurance Holdings Inc. | SLDE | 20.0 | $ 320.0 mil | 6/18/2025 Wednesday | S/O | S/O |
Last 100 IPOs - June 16, 2025
| Number of IPOs priced : | 100 |
| Number Up: | 58 |
| Number Down: | 39 |
| Number Unchanged: | 3 |
| Percentage Change From Issue Price: | 28.15% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2025 IPO Scorecard - June 16, 2025
| Number of IPOs priced (Excluding 54 units) : | 104 |
| Number Up: | 59 |
| Number Down: | 42 |
| Number Unchanged: | 3 |
| Total Return From Issue Price: | 26.39% |
| The Nasdaq Composite Index YTD % Change | 35.22% |